Medtech Insight is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Paradigm Spine (develops non-fusion spinal implants) raised $39mm in its Series E financing led by returning shareholder HealthCor Partners, which was joined by first-time backer Trevi Health Ventures and individual investors. The company will use the funds for the US launch of its recently approved DSS lumbar vertebrae system and to continue US trials of the coflex device for spinal stenosis.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?